Radiation-Free Alternative to Mammogram on the Horizon
By Daniel Beris Posted on 25 Nov 2016 |
Image: Microbubbles could someday help detect breast cancer (Photo courtesy of TUE).
A new, accurate, ultrasonic mammography method could help identify cancerous tumors by blood vessels structure, without radiation, according to a new study.
Under development at the Eindhoven University of Technology (TUE; The Netherlands), dynamic contrast specific ultrasound tomography (DCS-UST) builds on a patient-friendly prostate cancer detection method called cumulative phase delay imaging (CPDI) which images and quantifies ultrasound contrast agent (UCA) kinetics. The technology is based on harmless microbubbles injected into the patient’s bloodstream; the microbubbles vibrate in the blood at the same frequency as the ultrasonic echo, as well as at twice that frequency - the so-called second harmonic.
This second harmonic is delayed by the gas bubbles; the more bubbles are encountered by the sound on its route, the bigger the delay compared to the original sound. By measuring this delay, the researchers can thus localize the air bubbles without any disturbance, since the second harmonic generated by the body tissue is not delayed, and is therefore discernible. This difference, however, can only be seen if the sound is captured on the other side. So the method is perfectly suited to organs that can be approached from two sides, like the breast.
An ultrasound scanner can thus be used to precisely track the microbubbles as they flow through the blood vessels. Since cancer growth is associated with the formation of chaotic microvessels, the presence and location of cancer become visible. What also makes the technique different to current mammography is the patient’s position. Instead of standing, the patient lies on a table, with the breast hanging freely in a bowl. The proof-of-concept study was published in the November 2016 issue of Scientific Reports.
“For breast imaging, DCS-UST will lead to a more practical, faster, and less operator-dependent imaging procedure compared to standard echo-contrast, while preserving accurate imaging of contrast kinetics,” concluded lead author Libertario Demi, PhD, of the TUE biomedical diagnostics laboratory. “DCS-UST can find clinical applications as a diagnostic method for breast cancer localization, adding important features to multi-parametric ultrasound tomography of the breast.”
Related Links:
Eindhoven University of Technology
Under development at the Eindhoven University of Technology (TUE; The Netherlands), dynamic contrast specific ultrasound tomography (DCS-UST) builds on a patient-friendly prostate cancer detection method called cumulative phase delay imaging (CPDI) which images and quantifies ultrasound contrast agent (UCA) kinetics. The technology is based on harmless microbubbles injected into the patient’s bloodstream; the microbubbles vibrate in the blood at the same frequency as the ultrasonic echo, as well as at twice that frequency - the so-called second harmonic.
This second harmonic is delayed by the gas bubbles; the more bubbles are encountered by the sound on its route, the bigger the delay compared to the original sound. By measuring this delay, the researchers can thus localize the air bubbles without any disturbance, since the second harmonic generated by the body tissue is not delayed, and is therefore discernible. This difference, however, can only be seen if the sound is captured on the other side. So the method is perfectly suited to organs that can be approached from two sides, like the breast.
An ultrasound scanner can thus be used to precisely track the microbubbles as they flow through the blood vessels. Since cancer growth is associated with the formation of chaotic microvessels, the presence and location of cancer become visible. What also makes the technique different to current mammography is the patient’s position. Instead of standing, the patient lies on a table, with the breast hanging freely in a bowl. The proof-of-concept study was published in the November 2016 issue of Scientific Reports.
“For breast imaging, DCS-UST will lead to a more practical, faster, and less operator-dependent imaging procedure compared to standard echo-contrast, while preserving accurate imaging of contrast kinetics,” concluded lead author Libertario Demi, PhD, of the TUE biomedical diagnostics laboratory. “DCS-UST can find clinical applications as a diagnostic method for breast cancer localization, adding important features to multi-parametric ultrasound tomography of the breast.”
Related Links:
Eindhoven University of Technology
Latest Ultrasound News
- Groundbreaking Technology Enables Precise, Automatic Measurement of Peripheral Blood Vessels
- Deep Learning Advances Super-Resolution Ultrasound Imaging
- Novel Ultrasound-Launched Targeted Nanoparticle Eliminates Biofilm and Bacterial Infection
- AI-Guided Ultrasound System Enables Rapid Assessments of DVT
- Focused Ultrasound Technique Gets Quality Assurance Protocol
- AI-Guided Handheld Ultrasound System Helps Capture Diagnostic-Quality Cardiac Images
- Non-Invasive Ultrasound Imaging Device Diagnoses Risk of Chronic Kidney Disease
- Wearable Ultrasound Platform Paves Way for 24/7 Blood Pressure Monitoring On the Wrist
- Diagnostic Ultrasound Enhancing Agent to Improve Image Quality in Pediatric Heart Patients
- AI Detects COVID-19 in Lung Ultrasound Images
- New Ultrasound Technology to Revolutionize Respiratory Disease Diagnoses
- Dynamic Contrast-Enhanced Ultrasound Highly Useful For Interventions
- Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis
- Artificial Intelligence Detects Heart Defects in Newborns from Ultrasound Images
- Ultrasound Imaging Technology Allows Doctors to Watch Spinal Cord Activity during Surgery
- Shape-Shifting Ultrasound Stickers Detect Post-Surgical Complications